Lack of association between proton pump inhibitor use and decline in cognitive performance in the ELSA-Brasil cohort-Reference-Cited by-同舟云学术

Lack of association between proton pump inhibitor use and decline in cognitive performance in the ELSA-Brasil cohort

Published:2021-05-20 Issue:11 Volume:77 Page:1725-1735
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

dos Santos Andrêza Soares,de Menezes Sara Teles,Bensenor Isabela M.,Goulart Alessandra Carvalho,Barreto Sandhi Maria,Figueiredo Roberta Carvalho^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-021-03156-3.pdf

Reference50 articles.

1. Namazi MR, Jowkar MD (2008) A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors. J Clin Pharm Ther 33:215–217. https://doi.org/10.1111/j.1365-2710.2008.00907.x

2. Goldstein FC, Steenland K, Zhao L, Wharton W, Levey AI, Hajjar I (2017) Proton pump inhibitors and risk of mild cognitive impairment and dementia. J Am Geriatr Soc 65:1969–1974. https://doi.org/10.1111/14956

3. Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953. https://doi.org/10.1001/jama.296.24.2947

4. Sarkar M, Hennessy S, Yang YX (2008) Proton-pump inhibitor use and the risk for community acquired pneumonia. Ann Intern Med 149:391–398. https://doi.org/10.7326/0003-4819-149-6-200809160-00005

5. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J et al (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238–246. https://doi.org/10.1001/jamainternmed.2015.7193